Mary E. Moreno

1.7k total citations
17 papers, 671 citations indexed

About

Mary E. Moreno is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Mary E. Moreno has authored 17 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 9 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Mary E. Moreno's work include HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (7 papers) and HIV/AIDS drug development and treatment (5 papers). Mary E. Moreno is often cited by papers focused on HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (7 papers) and HIV/AIDS drug development and treatment (5 papers). Mary E. Moreno collaborates with scholars based in United States, Slovakia and Australia. Mary E. Moreno's co-authors include Cheryl A. Stoddart, Joseph M. McCune, Valerie Linquist-Stepps, Christopher Bare, Sofiya A. Galkina, Jose Rivera, Barbara Sloan, Pheroze Joshi, Mary Keir and Ekaterina Maidji and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Mary E. Moreno

16 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Moreno United States 13 382 309 247 170 117 17 671
Valerie Linquist-Stepps United States 10 335 0.9× 219 0.7× 232 0.9× 182 1.1× 114 1.0× 10 561
Luann Borowski United States 15 315 0.8× 421 1.4× 109 0.4× 193 1.1× 139 1.2× 21 678
H. C. Lane United States 13 438 1.1× 379 1.2× 319 1.3× 252 1.5× 85 0.7× 15 870
Praveen K. Amancha United States 11 292 0.8× 305 1.0× 162 0.7× 117 0.7× 61 0.5× 26 638
Manja Burggraf Germany 8 380 1.0× 306 1.0× 137 0.6× 158 0.9× 47 0.4× 8 637
Sofiya A. Galkina United States 8 202 0.5× 354 1.1× 174 0.7× 97 0.6× 49 0.4× 9 650
Megan K. Liszewski United States 11 422 1.1× 358 1.2× 261 1.1× 110 0.6× 56 0.5× 15 786
Françoise Gondois‐Rey France 14 423 1.1× 466 1.5× 277 1.1× 146 0.9× 106 0.9× 29 848
Houria Hendel France 12 609 1.6× 531 1.7× 187 0.8× 139 0.8× 63 0.5× 18 820
Rebecca Sabbe United States 8 378 1.0× 237 0.8× 245 1.0× 130 0.8× 107 0.9× 9 560

Countries citing papers authored by Mary E. Moreno

Since Specialization
Citations

This map shows the geographic impact of Mary E. Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Moreno more than expected).

Fields of papers citing papers by Mary E. Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Moreno. The network helps show where Mary E. Moreno may publish in the future.

Co-authorship network of co-authors of Mary E. Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Moreno. A scholar is included among the top collaborators of Mary E. Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Moreno. Mary E. Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Auyeung, Vincent C., Thorsten Steinberg, Mary E. Moreno, et al.. (2025). Pharmacologic inhibition of IRE1α-dependent decay protects alveolar epithelial identity and prevents pulmonary fibrosis in mice. Journal of Clinical Investigation. 135(20).
2.
Morvan, Maelig, Fernando Teque, Lin Ye, et al.. (2021). Genetically edited CD34 + cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells. Proceedings of the National Academy of Sciences. 118(20). 6 indexed citations
3.
Cham, Lamin B., Laughing Bear Torrez Dulgeroff, Michal Caspi Tal, et al.. (2020). Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection. Cell Reports. 31(2). 107494–107494. 31 indexed citations
4.
Maidji, Ekaterina, Mary E. Moreno, Jose Rivera, et al.. (2019). Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine (EFdA)-Suppressed Humanized Mice. Viruses. 11(3). 256–256. 7 indexed citations
5.
Laing, Steven T., S. Griffey, Mary E. Moreno, & Cheryl A. Stoddart. (2015). CD8-positive Lymphocytes in Graft-Versus-Host Disease of Humanized NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ Mice. Journal of Comparative Pathology. 152(2-3). 238–242. 7 indexed citations
6.
Stoddart, Cheryl A., Sofiya A. Galkina, Pheroze Joshi, et al.. (2015). Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque. Antimicrobial Agents and Chemotherapy. 59(7). 4190–4198. 65 indexed citations
7.
Stoddart, Cheryl A., Sofiya A. Galkina, Pheroze Joshi, et al.. (2014). Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice. Virology. 462-463. 115–125. 23 indexed citations
8.
Stoddart, Cheryl A., Ekaterina Maidji, Sofiya A. Galkina, et al.. (2011). Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ−/− (NSG) BLT mice. Virology. 417(1). 154–160. 81 indexed citations
9.
Stoddart, Cheryl A., Sofiya A. Galkina, April Kinkade, et al.. (2007). Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals. PLoS ONE. 2(8). e655–e655. 47 indexed citations
10.
Stoddart, Cheryl A., Romas Geleziunas, Valerie Linquist-Stepps, et al.. (2003). Human Immunodeficiency Virus Type 1 Nef-Mediated Downregulation of CD4 Correlates with Nef Enhancement of Viral Pathogenesis. Journal of Virology. 77(3). 2124–2133. 81 indexed citations
11.
Keir, Mary, Cheryl A. Stoddart, Valerie Linquist-Stepps, Mary E. Moreno, & Joseph M. McCune. (2002). IFN-α Secretion by Type 2 Predendritic Cells Up-Regulates MHC Class I in the HIV-1-Infected Thymus. The Journal of Immunology. 168(1). 325–331. 73 indexed citations
12.
Gobbi, Alberto, Cheryl A. Stoddart, Giuseppe Locatelli, et al.. (2000). Coinfection of SCID-hu Thy/Liv Mice with Human Herpesvirus 6 and Human Immunodeficiency Virus Type 1. Journal of Virology. 74(18). 8726–8731. 15 indexed citations
13.
Stoddart, Cheryl A., Mary E. Moreno, Valerie Linquist-Stepps, et al.. (2000). Antiviral Activity of 2′-Deoxy-3′-Oxa-4′-Thiocytidine (BCH-10652) against Lamivudine-Resistant Human Immunodeficiency Virus Type 1 in SCID-hu Thy/Liv Mice. Antimicrobial Agents and Chemotherapy. 44(3). 783–786. 23 indexed citations
14.
Dittmer, Dirk P., Cheryl A. Stoddart, Rolf Renne, et al.. (1999). Experimental Transmission of Kaposi's Sarcoma–Associated Herpesvirus (Kshv/Hhv-8) to Scid-Hu Thy/Liv Mice. The Journal of Experimental Medicine. 190(12). 1857–1868. 87 indexed citations
15.
Berkowitz, Robert D., Angélique B. van ’t Wout, Neeltje A. Kootstra, et al.. (1999). R5 Strains of Human Immunodeficiency Virus Type 1 from Rapid Progressors Lacking X4 Strains Do Not Possess X4-Type Pathogenicity in Human Thymus. Journal of Virology. 73(9). 7817–7822. 18 indexed citations
16.
Berkowitz, Robert D., Christopher Bare, Valerie Linquist-Stepps, et al.. (1998). CCR5- and CXCR4-Utilizing Strains of Human Immunodeficiency Virus Type 1 Exhibit Differential Tropism and Pathogenesis In Vivo. Journal of Virology. 72(12). 10108–10117. 85 indexed citations
17.
Stoddart, Cheryl A., Linda Rabin, Mara Hincenbergs, et al.. (1998). Inhibition of Human Immunodeficiency Virus Type 1 Infection in SCID-hu Thy/Liv Mice by the G-Quartet-Forming Oligonucleotide, ISIS 5320. Antimicrobial Agents and Chemotherapy. 42(8). 2113–2115. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie Linquist-Stepps Breakdown of academic impact, for papers by Luann Borowski Breakdown of academic impact, for papers by H. C. Lane Breakdown of academic impact, for papers by Praveen K. Amancha Breakdown of academic impact, for papers by Manja Burggraf Breakdown of academic impact, for papers by Sofiya A. Galkina Breakdown of academic impact, for papers by Megan K. Liszewski Breakdown of academic impact, for papers by Françoise Gondois‐Rey Breakdown of academic impact, for papers by Houria Hendel Breakdown of academic impact, for papers by Rebecca Sabbe
Rankless by CCL
2026